News

The scanner and associated software are used to detect and provide a quantitative measurement of HER2/neu, a protein that is measured in breast cancer patients in order to

According to Abbott, a key facet of CELL-DYN Emerald is its compact size – weighing just 9kg – as well as its intuitive software interface that allows for

Laurence Birch, president and CEO of NeoPharm, said: “The preliminary results from our Phase I trial, which has not yet concluded, have been encouraging. As a result, we

Dr Caspari’s initial primary responsibilities will include managing the development, FDA clinical trial and submission activities for AppyScore, the company’s diagnostic test for human appendicitis. Most recently, Dr

The Sleuth products offer physicians the ability to diagnose patients with recurrent, unexplained fainting and abnormal heart rhythms quickly with its virtually unlimited memory capacity and hands-free downloading

In addition, Mr Grossman will also be assuming the role of co-CEO, with no remuneration, to assist in XTL’s analysis of its strategic alternatives. Mr Grossman served as

The clinical study will assess the performance of OralAdvance compared to the gold standard biopsy and histology for its ability to differentiate between visually suspicious oral lesions with

Jeffrey Buchalter, chairman and CEO of Enzon, said: “As we previously demonstrated, Enzon maintains high standards for developing its important and novel compounds. While it did not achieve

Mr Blanchard brings more than 20 years of leadership experience in the global life sciences market to his new role, including senior level positions in corporate development, operations